CervoMed Announces Presentations at Upcoming AD/PDTM 2026 Scientific Conference
CervoMed plans to present vital data at the upcoming AD/PD™ 2026 Scientific Conference, reinforcing the rationale for its Phase 3 dementia trial. The findings aim to shed new light on patient population and dosing regimen decisions.
23 hours ago
1 min read
